Recurrent Breast Cancer Active Not Recruiting Phase 2 Trials for Lapatinib (DB01259)

Also known as: Breast Cancer Recurrent / Breast cancer NOS recurrent / Carcinoma breast recurrent / Breast carcinoma recurrent / Breast carcinoma NOS recurrent

DBCOND0028640 (Recurrent Breast Cancer)Active Not Recruiting2 IdentifierTitlePurposeDrugs
NCT01873833Capecitabine, Cyclophosphamide, Lapatinib Ditosylate, and Trastuzumab in Treating Patients With HER2-Positive Metastatic Breast CancerTreatment